Thermo Fisher nears $10 billion takeover of drug trial software maker Clario

 Life sciences group Thermo Fisher is nearing an all-cash takeover of drug trial software maker Clario in a deal that could value the healthcare technology group at approximately $10 billion, the Financial Times reported on Tuesday.

Reuters could not immediately verify the report.

https://www.marketscreener.com/news/thermo-fisher-nears-10-billion-takeover-of-drug-trial-software-maker-clario-ft-reports-ce7d5dddda8bf724